View All

Our Recent Articles

Dive virtually into a kaleidoscope of insights by the ASCO and keep a tab on all the strategic collaborations, significantly growing pipeline, oncology market trends, and the dynamism of healthcare vertical.

+ SHOW MORE
+ SHOW MORE
Loading
View All

Reports

NEWSLETTER AND WHITEPAPERS

Intra-Tumoral Cancer Therapies in Melanoma

Intra-Tumoral Cancer Therapies in Melanoma

Melanoma is the fifth most common cancer in the US and accounts for 1.7% of all diagnosed cancer cases across the globe. The number of melanoma diagnoses is expected to increase by more than 50% by 2040. Currently, several pharma goliaths are developing intra-tumoral cancer therapies for melanoma.

Download Now